SuppreMol's Series D Round

SuppreMol raised a round of funding on September 01, 2012.

SuppreMol is a privately held biopharmaceutical company developing therapeutics for the treatment of autoimmune and allergic diseases. The company is pioneering the development of soluble Fc-gamma rec…

Articles about SuppreMol's Series D Round: